Advertisement
Serum Institute of India
Premium
Healthcare
24 July, 2023
Advent may rope in new investor for Bharat Serums with neat valuation markup
Mumbai-based biopharmaceutical company Bharat Serums, controlled by private equity major Advent International, is looking to onboard new investor(s) for a ......
Premium
Finance
19 December, 2022
Poonawalla to target growth-stage firms with ₹1,000 cr fund
Adar Poonawalla, chief executive of Serum Institute of India, has sought regulatory approval to establish the Poonawalla Vision Fund to ......
Premium
Finance
06 April, 2022
India Alternatives garners 5x returns on its first exit from second fund
The family office of Adar Poonawalla, who is the CEO of the world's largest manufacturer of vaccines by volume, Serum ......
Premium
Finance
24 April, 2020
Serum Institute's Adar Poonawalla bets $40 mn on Mumbai NBFC
Adar Poonawalla, CEO at vaccine maker Serum Institute of India Pvt. Ltd, has invested in a non-banking finance company, a ......
Advertisement
Recommended for you
Advertisement